Literature DB >> 27355995

Treatment of hypertension and the price to pay; adverse events and discontinuation from randomized treatment in clinical trials.

Sverre E Kjeldsen1, Ingrid Os, Josep Redon.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27355995     DOI： 10.1097/HJH.0000000000001002

Source DB:  PubMed          Journal:  J Hypertens        ISSN： 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  2 in total

1.  MicroRNA-199a-5p aggravates primary hypertension by damaging vascular endothelial cells through inhibition of autophagy and promotion of apoptosis.

Authors:  Xintao Tian; Chunpeng Yu; Lei Shi; Dan Li; Xiaoxue Chen; Di Xia; Jingwei Zhou; Wanqun Xu; Chengtai Ma; Lihua Gu; Yi An
Journal:  Exp Ther Med       Date:  2018-06-06       Impact factor: 2.447

2.  Uncontrolled Hypertension Increases with Age in an Older Community-Dwelling Chinese Population in Shanghai.

Authors:  Sheng Peng; Ting Shen; Jie Liu; Brian Tomlinson; Huimin Sun; Xiaoli Chen; Paul Chan; YaShu Kuang; Liang Zheng; Hong Wu; Xugang Ding; Dingguang Qian; Yixin Shen; Pingjin Gao; Huimin Fan; Zhongmin Liu; Yuzhen Zhang
Journal:  Aging Dis       Date:  2017-10-01       Impact factor: 6.745
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.